Key facts
- Notable investors include Bonaventure Capital.
- Status: Privately Held (backing).
Investors
1- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for Motus Nova
- ·The full record, as it builds
Funding rounds
No funding rounds for Motus Nova are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Motus Nova
Developer of rehabilitation robots designed to enhance the rehabilitation process after stroke through robotic exoskeletons guided by artificial intelligence. The company's product uses high-dose repetitive task practice to induce neuroplasticity as well as features patented assistive technology, a monitor that displays games that provide the user with an interactive way to do their, biofeedback to rewire brain signals, and more thereby helping stroke survivors improve hand and foot function.
- Sector
- Healthcare
- HQ
- Atlanta, GA, United States
- Founded
- 2013
- Employees
- 42
- Website
- motusnova.com/
- Ownership
- Privately Held (backing)
Motus Nova doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Motus Nova shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Motus Nova in its N-PORT filings yet. We sweep new filings monthly.